CNX
59
-2
COP
45
-5
WBA
41
-2
PSX
44
-5
EW
56
-12
T
41
-4
JPM
52
3
CTSH
59
-4
CI
58
-4
EXC
45
-5
AIV
27
-2
IFF
48
-3
PSA
60
-11
TXT
68
-4
BEN
56
-4
BLK
38
-5
PHM
58
-12
AES
58
-2
DVA
57
-10
PPG
49
-3
CNX
59
-2
COP
45
-5
WBA
41
-2
PSX
44
-5
EW
56
-12
T
41
-4
JPM
52
3
CTSH
59
-4
CI
58
-4
EXC
45
-5
AIV
27
-2
IFF
48
-3
PSA
60
-11
TXT
68
-4
BEN
56
-4
BLK
38
-5
PHM
58
-12
AES
58
-2
DVA
57
-10
PPG
49
-3
Financhill
Back

NovoCure Quote, Financials, Valuation and Earnings

Global Leader In Plant Cell Biology Poised For Rapid Growth!

Click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!
Buy
74

NVCR
NovoCure

Last Price:
94.18
Seasonality Move:
17.81%

7 Day Trial

ALL ACCESS PASS

$ 7

Your Chance To Invest In The Green Energy Revolution!

Don't miss this one - click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!

NovoCure Price Quote

$94.18
-0.04 (-0.96%)
(Updated: February 4, 2023 at 4:26 AM ET)

NovoCure Key Stats

Buy
74
NovoCure (NVCR) is a Buy
Day range:
$92.20 - $95.13
52-week range:
$56.39 - $120.03
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
18.13
P/B ratio:
22.2%
Volume:
743K
Avg. volume:
1.4M
1-year change:
35.92%
Market cap:
$9.9B
Revenue:
$535M
EPS:
$-0.77

How Much Does NovoCure Make?

  • How Much Are NovoCure's Sales Annually?
    NVCR Revenues are $535M
  • How Much Profit Does NovoCure's Make A Year?
    NVCR net income is -$58.4M

Is NovoCure Growing As A Company?

  • What Is NovoCure's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.02%
  • What Is NovoCure's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

NovoCure Stock Price Performance

  • Did NovoCure Stock Go Up Last Month?
    NovoCure share price went up by 38.68% last month
  • Did NVCR's Share Price Rise Over The Last Year?
    NVCR share price rose by 35.92% over the past 1 year

What Is NovoCure 52-Week High & Low?

  • What Is NovoCure’s 52-Week High Share Price?
    NovoCure has traded as high as $120.03 over the past 52 weeks
  • What Is NovoCure’s 52-Week Low Share Price?
    NovoCure has traded as low as $56.39 over the past 52 weeks

NovoCure Price To Free Cash Flow

  • Is NovoCure Stock Overvalued?
    NovoCure is trading at a price to free cash flow ratio of 499.35
  • Is NovoCure Stock Undervalued?
    NovoCure EV to Free Cash Flow ratio is 481.41
  • What Is NovoCure’s Price Earnings Growth Ratio?
    NVCR PEG ratio is -0.66
  • Is NovoCure Trading At A Premium To Earnings?
    NovoCure EV to EBIT ratio is 0.00

Is It Risky To Buy NovoCure?

  • How Much Debt Does NovoCure Have?
    Total long term debt quarterly is $564.7M
  • How Much Cash Does NovoCure Have?
    Cash and short term investments quarterly total is $970.3M
  • What Is NovoCure’s Book Value Per Share?
    Book value per share is 4.24

Is NovoCure Cash Flow Positive?

  • What Is NVCR Cash Flow From Operations?
    Cash flow from operations (TTM) is $48.9M
  • What Is NovoCure’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $15.7M
  • What Is NovoCure’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$511M

NovoCure Return On Invested Capital

  • Is Management Doing A Good Job?
    NVCR return on invested capital is -8.23%
  • What Is NovoCure Return On Assets?
    ROA measures how assets are converting to revenues and is -7.11%
  • What Is NVCR Return On Equity?
    ROE is a measure of profitability and is -19.03%

NovoCure Earnings Date & Stock Price

  • What Is NovoCure's Stock Price Today?
    A single share of NVCR can be purchased today for 94.22
  • What Is NovoCure’s Stock Symbol?
    NovoCure trades on the nasdaq under the ticker symbol: NVCR
  • When Is NovoCure’s Next Earnings Date?
    The next quarterly earnings date for NovoCure is scheduled on February 23, 2023
  • When Is NVCR's next ex-dividend date?
    NovoCure's next ex-dividend date is February 4, 2023
  • How To Buy NovoCure Stock?
    You can buy NovoCure shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

NovoCure Competitors

  • Who Are NovoCure's Competitors?
    Below is a list of companies who compete with NovoCure or are related in some way:
    • Asensus Surgical Inc (ASXC)
    • Boston Scientific Corp (BSX)
    • Isoray Inc (ISR)
    • Insulet Corp (PODD)
    • Xtant Medical Holdings Inc (XTNT)

NovoCure Dividend Yield

Data Unavailable

NovoCure Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 2.77%
Revenue: -1.95% -1.79%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 3
Sell Recommendations: 2
Price Target: 103.75
Upside from Last Price: 10.11%

Major Shareholders

  • How many NVCR shares are owned by institutional investors?
    170.3M NVCR shares are owned by institutional investors
  • How many NVCR shares are owned by insiders?
    8.1M NVCR shares are owned by insiders